These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8739602)

  • 1. Efficacy of BMS-180194 against experimental cytomegalovirus infections in immunocompromised mice.
    Yang H; Drain RL; Franco CA; Clark JM
    Antiviral Res; 1996 Mar; 29(2-3):233-41. PubMed ID: 8739602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral activity of 9-[[(ethoxyhydroxyphosphinyl)-methoxy]methoxy] guanine against cytomegalovirus and herpes simplex virus.
    Kim HT; Kim DK; Kim YW; Kim KH; Sugiyama Y; Kikuchi M
    Antiviral Res; 1995 Nov; 28(3):243-51. PubMed ID: 8629816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose and duration-dependence of ganciclovir treatment against murine cytomegalovirus infection in severe combined immunodeficient mice.
    Duan J; Paris W; Kibler P; Bousquet C; Liuzzi M; Cordingley MG
    Antiviral Res; 1998 Oct; 39(3):189-97. PubMed ID: 9833959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral activities of nucleosides and nucleotides against wild-type and drug-resistant strains of murine cytomegalovirus.
    Smee DF; Barnett BB; Sidwell RW; Reist EJ; Holy A
    Antiviral Res; 1995 Jan; 26(1):1-9. PubMed ID: 7741517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo activity of 1-O-hexadecylpropanediol-3-phospho-ganciclovir and 1-O-hexadecylpropanediol-3-phospho-penciclovir in cytomegalovirus and herpes simplex virus infections.
    Hostetler KY; Rybak RJ; Beadle JR; Gardner MF; Aldern KA; Wright KN; Kern ER
    Antivir Chem Chemother; 2001 Jan; 12(1):61-70. PubMed ID: 11437323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent anti-murine cytomegalovirus activity and reduced nephrotoxicity of ganciclovir cyclic phosphonate.
    Smee DF; Reist EJ
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1964-6. PubMed ID: 8843317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New inhibitors of cytomegalovirus replication: in vitro evaluation, mechanism of action, and in vivo activity.
    Neyts J; De Clercq E
    Verh K Acad Geneeskd Belg; 1994; 56(6):561-92. PubMed ID: 7892749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of antiviral immunotoxin and ganciclovir or cidofovir for the treatment of murine cytomegalovirus infections.
    Smee DF; Sidwell RW; Barnett BB
    Antiviral Res; 1996 Nov; 32(3):165-71. PubMed ID: 8955511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between human cytomegalovirus pUL97 and murine cytomegalovirus (MCMV) pM97 expressed by MCMV and vaccinia virus: pM97 does not confer ganciclovir sensitivity.
    Wagner M; Michel D; Schaarschmidt P; Vaida B; Jonjic S; Messerle M; Mertens T; Koszinowski U
    J Virol; 2000 Nov; 74(22):10729-36. PubMed ID: 11044117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective treatment of murine cytomegalovirus infections with methylenecyclopropane analogues of nucleosides.
    Rybak RJ; Zemlicka J; Qiu YL; Hartline CB; Kern ER
    Antiviral Res; 1999 Oct; 43(3):175-88. PubMed ID: 10551375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ganciclovir transiently attenuates murine cytomegalovirus-associated renal allograft inflammation.
    Shimamura M; Saunders U; Rha B; Guo L; Cassady KA; George JF; Britt WJ
    Transplantation; 2011 Oct; 92(7):759-66. PubMed ID: 21878840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleotide analogs related to acyclovir and ganciclovir are effective against murine cytomegalovirus infections in BALB/c and severe combined immunodeficient mice.
    Smee DF; Sugiyama ST; Reist EJ
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2165-8. PubMed ID: 7811037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of ganciclovir in combination with zidovudine against cytomegalovirus in vitro and in vivo.
    Freitas VR; Fraser-Smith EB; Chiu S; Michelson S; Schatzman RC
    Antiviral Res; 1993 Aug; 21(4):301-15. PubMed ID: 8215302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Broad-spectrum antiviral activity of PNU-183792, a 4-oxo-dihydroquinoline, against human and animal herpesviruses.
    Brideau RJ; Knechtel ML; Huang A; Vaillancourt VA; Vera EE; Oien NL; Hopkins TA; Wieber JL; Wilkinson KF; Rush BD; Schwende FJ; Wathen MW
    Antiviral Res; 2002 Apr; 54(1):19-28. PubMed ID: 11888654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aerosol administration of antiviral agents to treat lung infection due to murine cytomegalovirus.
    Debs RJ; Montgomery AB; Brunette EN; DeBruin M; Shanley JD
    J Infect Dis; 1988 Feb; 157(2):327-31. PubMed ID: 2826613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral activity of a methylenecyclopropane analog, cyclopropavir, in animal models for cytomegalovirus infections.
    Kern ER; Bidanset DJ; Hartline CB; Yan Z; Zemlicka J; Quenelle DC
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4745-53. PubMed ID: 15561852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration.
    Orange JS; Wang B; Terhorst C; Biron CA
    J Exp Med; 1995 Oct; 182(4):1045-56. PubMed ID: 7561678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo imaging assay for the convenient evaluation of antiviral compounds against cytomegalovirus in mice.
    Yamada S; Kosugi I; Katano H; Fukui Y; Kawasaki H; Arai Y; Kurane I; Inoue N
    Antiviral Res; 2010 Oct; 88(1):45-52. PubMed ID: 20633578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cytomegalovirus infection and its possible treatment with herbal medicines].
    Shiraki K; Yukawa T; Kurokawa M; Kageyama S
    Nihon Rinsho; 1998 Jan; 56(1):156-60. PubMed ID: 9465682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of monoclonal antibody combined with ganciclovir or (S)-1-[3-hydroxy-(2-phosphonylmethoxy)-propyl]cytosine against murine cytomegalovirus infections in cell culture and in severe combined immunodeficient mice.
    Smee DF; Sugiyama ST; Sidwell RW; Barnett BB
    Chemotherapy; 1995; 41(2):141-8. PubMed ID: 7758358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.